期刊文献+

脐血总有核细胞数对脐血移植疗效的影响 被引量:4

Influence of total nucleated cell dose on the efficacy of cord blood transplantation
原文传递
导出
摘要 目的探讨脐血总有核细胞(TNC)剂量对脐血移植疗效的影响。方法 34例血液病患儿接受脐血移植,按照输注平均脐血总TNC数分为3组:TNC>10×107/kg组7例、10×107/kg>TNC≥7×107/kg组9例、TNC<7×107/kg组18例。评估3组患儿造血干细胞植入、排斥、移植疗效。结果 TNC>10×107/kg组7例,均获得长期稳定植入,平均中性粒细胞计数(ANC)>0.5×109/L时间为14.8(12~20)d,PLT>50×109/L时间为52.3(26~86)d,处于无病存活状态。10×107/kg>TNC≥7×107/kg组9例,7例获得植入,平均ANC>0.5×109/L时间为16.4(11~30)d,PLT>50×109/L时间为63.7(34~140)d;4例获得长期稳定植入,无病存活;2例重型β-地中海贫血患者植入后出现排斥,恢复自身造血;1例植入后死亡;1例移植后早期死亡。TNC<7×107/kg组18例,16例获得植入,平均ANC>0.5×109/L时间为19.5(10~29)d,PLT>50×109/L时间为70.1(47~116)d;8例长期稳定植入,无病存活,2例重型β-地中海贫血患者在植入后出现移植排斥,自身造血功能恢复;6例植入后死亡;2例未植入。结论脐血TNC剂量是影响脐血移植中造血干细胞植入时间和嵌合状态的重要因素。增加输注的TNC细胞数可提高脐血移植成功率。 Objective To study the influence of cord blood total nucleated cell(TNC) dose on the efficacy of cord blood transplantation in children.Methods Thirty-four children with hematological disease received cord blood transplantation.They were assigned to 3 groups according to the infused TNC dose:TNC 〉10 × 10^7 /kg(n = 7),10 × 10^7 /kg TNC≥7 × 10^7 /kg(n = 9) and TNC 〈7 × 10^7 /kg(n = 18).The rates of graft and rejection of hematopoietic stem cells and the efficacy of transplantation were examined in the three groups.Results All 7 children in the group infused with TNC 〉10 × 10^7 /kg got a long-term stable engraftment.The median time of absolute neutrophil count 〉0.5 × 10^9 /L was 14.8 days(range 12-20 days) and platelets 〉50 × 10^9 /L was 52.3 days(range 26-86 days).They survived in a disease-free state.Of the 9 children in the group infused with TNC between 10 × 10^7 /kg and 7 × 10^7 /kg,7 got engraftment.The median time of absolute neutrophil count 〉0.5 × 10^9 /L was 16.4 days(range 11-30 days) and platelets 〉50 × 10^9 /L was 63.7 days(range 34-140 days).Four children got a long-term stable engraftment and survived in a disease-free state.Two children with beta-thalassemia major had secondary rejection after engraftment and autologous hematopoitic recovery.One child died after engraftment and one child died in the early period after transplantation.Of the 18 children in the group infused with TNC 〈7 × 10^7 /kg,16 children got engraftment.The median time of absolute neutrophil count 〉0.5 × 10^9 /L was 19.5 days(range 10-29 days) and platelets 〉50 × 10^9 /L was 70.1 days(range 41116 days).Eight children had a long-term stable engraftment and survived in a disease-free state.Two children with betathalassemia major had secondary rejection after engraftment and autologous hematopoitic recovery.Six children died after engraftment.Two children had graft failure.Conclusions TNC dose is an important influencing factor for hematopoietic stem cell engraftment in cord blood transplantation.An increased TNC dose may improve the success of cord blood transplantation.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2010年第7期551-556,共6页 Chinese Journal of Contemporary Pediatrics
关键词 脐血移植 造血干细胞 植入 儿童 Cord blood transplantation Hematopoietic stem cell Engraftment Child
  • 相关文献

参考文献14

  • 1顾龙君,孙桂香,卢新天,汤静燕,吴敏媛.小儿急性淋巴细胞白血病诊疗建议(第二次修订草案)[J].中华儿科杂志,1999,37(5):305-307. 被引量:304
  • 2Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia with bone marrow transplantation [ J ]. Bone Marrow Transplant, 2001, 28 :S11-S13.
  • 3Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and unbilical cord blood transplants in children with acute leukemia[ J ]. Blood, 2001, 97 (10) :2962-2971.
  • 4廖灿,刘斌,黄以宁,许遵鹏,辜少玲,吴韶清,陈劲松,李焱,汤雪薇,谢杏梅.54例非亲缘脐血造血干细胞移植回顾性分析[J].中国实验血液学杂志,2005,13(2):240-244. 被引量:2
  • 5Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group[ J]. N Engl J Med, 1997, 337(6) :373-381.
  • 6Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, et al. Results of the Cord Blood Transplantation Study (COBLT) : clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies [ J ]. Blood, 2008, 112 ( 10 ) :4318-4327.
  • 7Gluckman E. Hematopoietic stem-cell transplants using umbilicalcord blood[J]. N Engl J Med, 2001, 344(24) :1860-1861.
  • 8Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C,et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival[J]. Blood, 2002, 100(5) : 1611-1618.
  • 9Styczynski J, Cheung YK, Garvin J, Savage DG, Billote GB, Harrison L, et al. Outcomes of unrelated cord blood transplantation in pediatric recipients [ J]. Bone Marrow Transplant, 2004, 34(2), 129-136.
  • 10Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood [ J ]. Biol Blood Marrow Transplant, 2002,8 ( 7 ) : 368-376.

二级参考文献21

  • 1Femandez MN,Regidor C,Cabrera R,et al.Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells as ascertained by analysis of DNA polymorphisms.B
  • 2Gluckman E,Broxmeyer HA,Auerbach AD,et al.Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbili-cal-cord blood from an HLA-identical sibling.N Engl J Med,1989;321:1174 - 1178
  • 3Gluckman E,Rochar V,Chastang CI.Cord blood banking and transplant in Europe.Eurocord.Bone Marrow Transplant,1998;22(suppl 1) :s68 - 74
  • 4Femandez MN,Granena A,Nillan I,et al.Evaluation of engraftment of ex vivo expanded cord blood cells in humans.Bone Marrow Transplant,2000; 25(suppl 2) :s61 - 76
  • 5Donckier V,Toungouz M,Goldman M.Transplantation tolerance and mixed chimerism: at the frontier of clinical application,Tranpl Int,2001; 14:1-5
  • 6Grewal SS,Barker JN,Davies SM,et al.Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood,2003; 101:4233 - 4244
  • 7Rocha V,Cornish J,Sievers EL,et al.Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.Blood,2001; 97:2962 - 2971
  • 8Gluckman E, Broxemeyer HA, Auerbach AD. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilicalcord blood from an HLA-identical sibling, lN Engl J Med, 1989;321:1174 - 1178.
  • 9Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol, 2002; 14: 160 - 164.
  • 10Wadlow RC, Porter DL. Umbilical cord blood transplantation: where do we stand? Biol Blood Marrow Transplant, 2002; 8:637 -647.

共引文献306

同被引文献47

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部